AnaptysBio
ANAB
ANAB
127 hedge funds and large institutions have $749M invested in AnaptysBio in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 42 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.88% less ownership
Funds ownership: 101.54% → 100.67% (-0.88%)
29% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 42
Holders
127
Holding in Top 10
2
Calls
$673K
Puts
$300K
Top Buyers
| 1 | +$12.9M | |
| 2 | +$8.91M | |
| 3 | +$4.05M | |
| 4 |
EP
Eversept Partners
New York
|
+$2.12M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.35M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$8.55M | |
| 3 | -$4.22M | |
| 4 |
Two Sigma Advisers
New York
|
-$2.69M |
| 5 |
Morgan Stanley
New York
|
-$2.43M |